English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Mar 20, 2026
Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
B. D. Benavides
| Mar 18, 2026
Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
Patient Daily
| Mar 18, 2026
American Tort Reform Association releases report on scientific claims in mass tort litigation
Patient Daily
| Mar 12, 2026
Texas Medical Association announces concerns over pharmacy benefit manager consolidation
Patient Daily
| Mar 9, 2026
Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
Patient Daily
| Mar 5, 2026
TPA Director: RFK Jr.'s 'latest ideological crusade would be great for trial lawyers, but terrible for millions of patients'
A. B. Abbott
| Mar 4, 2026
Rep. Pappas: Proposed federal student loan policy ‘will make it harder for nursing students to access the loans they need’
Patient Daily
| Feb 25, 2026
BlackDoctor.org calls for reforms to federal 340B drug pricing program
Trending
+
Regulatory
B. D. Benavides
| Mar 18, 2026
Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+
Pharmaceuticals
Patient Daily
| Mar 22, 2026
BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+
Regulatory
Patient Daily
| Mar 20, 2026
Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+
Pharmaceuticals
Patient Daily
| Mar 17, 2026
Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference
1
2
»
Last »
